Prenetics Global Limited
PRE • NASDAQ
Prenetics Global Limited is a medical - diagnostics & research company in the healthcare sector trading on NASDAQ, led by CEO Sheng Wu Yeung, with a market cap of $345.0M.
CEOSheng Wu Yeung
Next Earnings
Upcoming earnings announcement for Prenetics Global Limited
Date
Thursday, June 11, 2026 (in 2 months)
Timing
Before Market Open (8:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.55
Revenue Estimate
$37.0M
Earnings History
Past 12 earnings reports for Prenetics Global Limited
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 18, 2026 | Q4 2025 | -$1.77 | — | $36.6M | — | — |
| Nov 10, 2025 | Q3 2025 | -$0.41Est: -$0.29 | -41.4% | $23.6MEst: $31.6M | -25.5% | — |
| Sep 12, 2025 | Q2 2025 | -$0.82Est: -$0.57 | -43.9% | $17.7MEst: $27.2M | -35.0% | — |
| Jun 12, 2025 | Q1 2025 | -$0.80Est: -$0.80 | 0.0% | $17.3MEst: $12.0M | +44.3% | — |
| Nov 27, 2024 | Q3 2024 | -$0.84Est: -$0.86 | +2.3% | $7.8MEst: $9.2M | -15.5% | — |
| Oct 7, 2024 | Q2 2024 | -$0.88Est: -$0.93 | +5.4% | $5.9MEst: $7.7M | -22.8% | — |
| Jun 18, 2024 | Q1 2024 | -$0.38 | — | $6.4M | — | — |
| Apr 1, 2024 | Q4 2023 | -$0.51Est: -$0.75 | +32.0% | $5.4MEst: $17.6M | -69.2% | — |
| Nov 20, 2023 | Q3 2023 | -$0.05Est: -$0.05 | 0.0% | $4.9MEst: $18.1M | -73.2% | — |
| Sep 15, 2023 | Q2 2023 | -$0.75Est: -$0.75 | 0.0% | $5.7MEst: $26.0M | -78.1% | — |
| Jun 5, 2023 | Q1 2023 | -$0.60Est: $0.90 | -166.7% | $17.7MEst: $24.2M | -26.9% | — |
| Mar 14, 2023 | Q4 2022 | $0.90Est: -$1.50 | +160.0% | $52.3MEst: $55.0M | -4.8% | — |